Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients

Table 2 Description of the study sample (mean ± SD unless otherwise stated)

Variable (units; normal range)	Total (n = 146)
Gender (%; males)	54.1
Nutrition habits (score)	4.73 ± 1.45
BMI (kg/m2; 20-25)	31.56 ± 4.62
Age (yr)	47.76 ± 11.68
Education (%; high school and above)	66.7
Smoking (%; current smoker)	12.3
Time since diagnosis (%; one year or less)	36.0
HOMA-IR (score)	6.10 ± 2.79
HbA1C (%; 3.9-6)	5.65 ± 0.46
AST (U/L; 5-40)	32.66 ± 14.95
Glucose (mg/dL; 70-110)	85.62 ± 10.63
ALT (U/L; 5-39)	50.16 ± 34.12
GGT (U/L; 6-28)	48.29 ± 50.60
Albumin (g/L; 35-50)	45.05 ± 2.75
Total Cholesterol (mg/dL; 150-200)	187.97 ± 38.08
Ferritin (ng/mL; 7.1-151)	148.77 ± 129.31
Metabolic syndrome (%)	28.7
Lipid-lowering medications (%)	28.8
Antihypertensive medications (%)	20.5

Blood tests were available to 87 subjects.